Evolving trends in the management of pelvic inflammatory disease (PID) during SARS-CoV-2 pandemic: A multicenter retrospective cohort study.
G ScutieroCristina TalientoG VizzielliA VitaglianoG SoraciA SabattiniF SpelziniR CappadonaM TormenM ArcieriA ErcoliP GrecoPublished in: The journal of obstetrics and gynaecology research (2024)
In this retrospective cohort study, we found that the SARS-CoV-2 pandemic influenced the clinical presentation and management of PID in favor of conservative treatment. Patients who underwent surgery during the SARS-CoV-2 pandemic had higher inflammatory markers.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- end stage renal disease
- ejection fraction
- minimally invasive
- chronic kidney disease
- newly diagnosed
- coronavirus disease
- prognostic factors
- peritoneal dialysis
- coronary artery bypass
- rectal cancer
- acute coronary syndrome
- double blind
- surgical site infection
- combination therapy